269 related articles for article (PubMed ID: 22391319)
1. Hedgehog inhibition as an anti-cancer strategy.
Raju GP; Pham D
Vitam Horm; 2012; 88():507-22. PubMed ID: 22391319
[TBL] [Abstract][Full Text] [Related]
2. TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling.
Ibuki N; Ghaffari M; Pandey M; Iu I; Fazli L; Kashiwagi M; Tojo H; Nakanishi O; Gleave ME; Cox ME
Int J Cancer; 2013 Oct; 133(8):1955-66. PubMed ID: 23564295
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the design of Hedgehog pathway inhibitors for the treatment of malignancies.
Banerjee U; Hadden MK
Expert Opin Drug Discov; 2014 Jul; 9(7):751-71. PubMed ID: 24850423
[TBL] [Abstract][Full Text] [Related]
4. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.
Queiroz KC; Spek CA; Peppelenbosch MP
Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179
[TBL] [Abstract][Full Text] [Related]
5. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
Xu FG; Ma QY; Wang Z
Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy.
Scales SJ; de Sauvage FJ
Trends Pharmacol Sci; 2009 Jun; 30(6):303-12. PubMed ID: 19443052
[TBL] [Abstract][Full Text] [Related]
7. Modulators of the hedgehog signaling pathway.
Heretsch P; Tzagkaroulaki L; Giannis A
Bioorg Med Chem; 2010 Sep; 18(18):6613-24. PubMed ID: 20708941
[TBL] [Abstract][Full Text] [Related]
8. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.
Yauch RL; Dijkgraaf GJ; Alicke B; Januario T; Ahn CP; Holcomb T; Pujara K; Stinson J; Callahan CA; Tang T; Bazan JF; Kan Z; Seshagiri S; Hann CL; Gould SE; Low JA; Rudin CM; de Sauvage FJ
Science; 2009 Oct; 326(5952):572-4. PubMed ID: 19726788
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies.
Galperin I; Dempwolff L; Diederich WE; Lauth M
J Med Chem; 2019 Sep; 62(18):8392-8411. PubMed ID: 30986059
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog signaling pathway and cancer therapeutics: progress to date.
Ruch JM; Kim EJ
Drugs; 2013 May; 73(7):613-23. PubMed ID: 23605693
[TBL] [Abstract][Full Text] [Related]
11. Paracrine Hedgehog signaling in cancer.
Theunissen JW; de Sauvage FJ
Cancer Res; 2009 Aug; 69(15):6007-10. PubMed ID: 19638582
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells.
Kobune M; Takimoto R; Murase K; Iyama S; Sato T; Kikuchi S; Kawano Y; Miyanishi K; Sato Y; Niitsu Y; Kato J
Cancer Sci; 2009 May; 100(5):948-55. PubMed ID: 19245435
[TBL] [Abstract][Full Text] [Related]
13. Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers.
Li QR; Zhao H; Zhang XS; Lang H; Yu K
Acta Pharmacol Sin; 2019 Feb; 40(2):257-267. PubMed ID: 29777201
[TBL] [Abstract][Full Text] [Related]
14. Advances in targeting the Hedgehog signaling pathway in cancer therapy.
Kiesslich T; Neureiter D
Expert Opin Ther Targets; 2012 Feb; 16(2):151-6. PubMed ID: 22233124
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment.
Heller E; Hurchla MA; Xiang J; Su X; Chen S; Schneider J; Joeng KS; Vidal M; Goldberg L; Deng H; Hornick MC; Prior JL; Piwnica-Worms D; Long F; Cagan R; Weilbaecher KN
Cancer Res; 2012 Feb; 72(4):897-907. PubMed ID: 22186138
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with Hedgehog pathway inhibitors.
Low JA; de Sauvage FJ
J Clin Oncol; 2010 Dec; 28(36):5321-6. PubMed ID: 21041712
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth.
Campbell VT; Nadesan P; Ali SA; Wang CY; Whetstone H; Poon R; Wei Q; Keilty J; Proctor J; Wang LW; Apte SS; McGovern K; Alman BA; Wunder JS
Mol Cancer Ther; 2014 May; 13(5):1259-69. PubMed ID: 24634412
[TBL] [Abstract][Full Text] [Related]
18. Recent patents for Hedgehog pathway inhibitors for the treatment of malignancy.
Tremblay MR; Nesler M; Weatherhead R; Castro AC
Expert Opin Ther Pat; 2009 Aug; 19(8):1039-56. PubMed ID: 19505195
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Hedgehog Antagonists for Cancer Therapy.
Khatra H; Bose C; Sinha S
Curr Med Chem; 2017; 24(19):2033-2058. PubMed ID: 28302010
[TBL] [Abstract][Full Text] [Related]
20. Targeting the hedgehog pathway: role in cancer and clinical implications of its inhibition.
Cohen DJ
Hematol Oncol Clin North Am; 2012 Jun; 26(3):565-88, viii. PubMed ID: 22520980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
